- Home
- BNTX vs PHM Comparison
BNTX vs PHM Comparison
Compare BNTX & PHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- PHM
- Stock Information
- Founded
- BNTX 2008
- PHM 1950
- Country
- BNTX Germany
- PHM United States
- Employees
- BNTX N/A
- PHM N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- PHM Homebuilding
- Sector
- BNTX Health Care
- PHM Consumer Discretionary
- Exchange
- BNTX Nasdaq
- PHM Nasdaq
- Market Cap
- BNTX 23.9B
- PHM 27.2B
- IPO Year
- BNTX 2019
- PHM N/A
- Fundamental
- Price
- BNTX $121.72
- PHM $126.80
- Analyst Decision
- BNTX Strong Buy
- PHM Buy
- Analyst Count
- BNTX 14
- PHM 16
- Target Price
- BNTX $141.60
- PHM $145.00
- AVG Volume (30 Days)
- BNTX 1.1M
- PHM 1.5M
- Earning Date
- BNTX 11-04-2024
- PHM 01-30-2025
- Dividend Yield
- BNTX N/A
- PHM 0.63%
- EPS Growth
- BNTX N/A
- PHM 10.14
- EPS
- BNTX N/A
- PHM 13.56
- Revenue
- BNTX $3,390,698,192.00
- PHM $17,318,808,000.00
- Revenue This Year
- BNTX N/A
- PHM $11.29
- Revenue Next Year
- BNTX N/A
- PHM $4.29
- P/E Ratio
- BNTX N/A
- PHM $9.35
- Revenue Growth
- BNTX N/A
- PHM 2.80
- 52 Week Low
- BNTX $76.53
- PHM $93.99
- 52 Week High
- BNTX $131.49
- PHM $149.47
- Technical
- Relative Strength Index (RSI)
- BNTX 60.69
- PHM 39.16
- Support Level
- BNTX $112.96
- PHM $133.46
- Resistance Level
- BNTX $121.80
- PHM $136.14
- Average True Range (ATR)
- BNTX 5.01
- PHM 3.27
- MACD
- BNTX 1.07
- PHM -0.24
- Stochastic Oscillator
- BNTX 86.57
- PHM 10.22
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes, and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.